The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: A multicenter randomized phase II trial (OCUU-CRPC study).
 
Taro Iguchi
Speakers' Bureau - Astellas Pharma
Research Funding - Astellas Pharma (Inst)
 
Satoshi Tamada
No Relationships to Disclose
 
Minoru Kato
No Relationships to Disclose
 
Sayaka Yasuda
Research Funding - Astellas Pharma
 
Yuichi Machida
No Relationships to Disclose
 
Tetsuji Ohmachi
No Relationships to Disclose
 
Keiichi Ishii
No Relationships to Disclose
 
Hiroyuki Iwata
No Relationships to Disclose
 
Shinji Yamamoto
No Relationships to Disclose
 
Tomohiro Kanamaru
No Relationships to Disclose
 
Kazuya Morimoto
No Relationships to Disclose
 
Taro Hase
No Relationships to Disclose
 
Koichiro Tashiroro
No Relationships to Disclose
 
Koji Harimoto
No Relationships to Disclose
 
Takashi Deguhi
No Relationships to Disclose
 
Takahisa Adachi
No Relationships to Disclose
 
Katsuki Iwamoto
No Relationships to Disclose
 
Yoshinori Takegaki
No Relationships to Disclose
 
Tatsuya Nakatani
Research Funding - Astellas Pharma (Inst)